Uriage Presents New Scientific Advances in Triple Barrier Science at EADV Congress 2026 in Vienna

ConferenceXEMOSE C8+BARIEDERM-CICA+Positive

AI Analysis

Summary

Uriage presented scientific research on skin barrier repair and microbiome improvement at EADV Congress 2026 in Vienna, introducing XEMOSE C8+ and BARIEDERM-CICA+ products for atopic dermatitis treatment.

Importance:3/10

Sentiment:

0.30

dermatologyskin barriermicrobiomeatopic dermatitisconference presentationEADV Congress 2026

Related Companies

$GBIO

Read the original article

Published by PR Newswire Clinical Trials on October 1, 2026 7:16 PM

Read Original